did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

We're the #1 textbook rental company. Let us show you why.

9780130664297

AIDS Update 2002

by
  • ISBN13:

    9780130664297

  • ISBN10:

    0130664294

  • Format: Paperback
  • Copyright: 2001-12-01
  • Publisher: Pearson College Div
  • View Upgraded Edition
  • Purchase Benefits
  • Free Shipping Icon Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • eCampus.com Logo Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $38.80

Summary

For use in any course with significant coverage of AIDS, Virology, Immunology, Endocrinology, and Human Sexuality. This text requires no biology prerequisite, and is the most comprehensive, authoritative, accurate, and up-to-date textbook on HIV/AIDS currently available as it is updated each and every year. It presents the entire 17-year chronology of the AIDS pandemic in a reasonable, logical, and scientific manner that interweaves biological, clinical, social, and legal discoveries in a uniquely readable presentation.

Table of Contents

Preface xviii
Introduction: Histories of Global Pandemics, World AIDS Conferences, Overview of HIV/AIDS, and the AIDS Quilt 1(23)
Discovering AIDS, Naming the Disease
24(9)
Concepts
24(1)
AIDS: A Disease or a Syndrome?
24(1)
What Causes AIDS?
24(1)
How Does HIV Cause AIDS?
24(2)
Looking Back 1.1 The New York Times and A.I.D.S., August 8, 1982
26(1)
The Centers for Disease Control and Prevention Reports
26(1)
Discovery of the AIDS Virus
26(2)
Defining the Illness: AIDS Surveillance
28(3)
Summary
31(1)
Review Questions
31(1)
References
32(1)
What Causes AIDS: Origin of the AIDS Virus
33(19)
Chapter Concepts
33(1)
The Cause of AIDS: The Human Immunodeficiency Virus
33(6)
Box 2.1 Sex and HIV Do Not Cause AIDS!
34(2)
Box 2.2 Science Takes a Backseat to Politics
36(3)
Newsweek Magazine Again
39(1)
What Do You Believe and Why?
39(3)
Origin of HIV: The AIDS Virus
42(8)
Box 2.3 The Cause and Effect of Diseases: The Unbroken Chain
42(2)
Point of Information 2.1 Scientists Report on Earliest AIDS Case
44(4)
Box 2.4 Origin of HIV in Humans: A Competing Hypothesis
48(2)
Summary on the Origin of HIV
50(1)
Summary
50(1)
Review Questions
51(1)
References
51(1)
Biological Characteristics of the AIDS Virus
52(20)
Chapter Concepts
52(1)
Viruses Need Help
52(1)
Viruses Are Parasites
52(1)
Point of Information 3.1 Viral Specificity
53(1)
Retroviruses
53(1)
Human Immunodeficiency Virus (HIV)
53(3)
Basic Genetic Structure of Retroviral Genomes
56(8)
Genetic Revolution
64(1)
Formation of Genetic Mutations in HIV
64(1)
Formation of Genetic Recombination in HIV
64(2)
Distinct Genotypes (Subtypes/Clades) of HIV-1 Worldwide Based on ENV and GAG Proteins
66(3)
Point of Information 3.2 Mysteries of HIV Subtypes
68(1)
Point of Information 3.3 First Confirmed Cases of HIV Group O-Caused AIDS
69(1)
Summary
69(1)
Review Questions
70(1)
References
70(2)
Anti-HIV Therapy
72(41)
Chapter Concepts
72(1)
Goals for Anti-HIV Therapy
72(2)
Anti-HIV Drugs With FDA Approval
74(2)
Point of View 4.1 Medical Benefit: A Cure?
74(2)
FDA-Approved Nucleoside, Non-Nucleoside Analog Reverse Transcriptase Inhibitors and Protease Inhibitors
76(5)
Use of Non-Nucleoside Analog Reverse Transcriptase Inhibitors
81(1)
FDA-Approved Protease Inhibitors
81(1)
Protease Inhibitors
82(2)
Development and Selection of HIV Drug-Resistant Mutants
84(1)
Development of Drug-Resistant Protease Inhibitors
84(3)
Box 4.1 Protease Inhibitors: Extending Life; The Downside of this Gift---Recovery?
85(2)
How Combination Drug Therapy can Reduce the Chance of HIV Drug Resistance
87(5)
Point of Information 4.1 The Drug Development, Approval Process, and Clinical Trials
91(1)
HIV Therapy Cut-Off Points
92(1)
Viral Load: Its Relationship to HIV Disease and AIDS
92(3)
Sidebar 4.1 Personal Testimony on HIV Drug-Resistant Mutants
93(2)
Medical Complications Associated With Anti-HIV Drug Therapies
95(3)
Point of Information 4.2 Determination of Viral Load and Questions People Ask
96(2)
Point to Ponder 4.1 Ration of HIV/AIDS Physicians to the Population and the HIV-Infected
98(1)
Update
98(1)
Sidebar 4.2 Monetary Reasons for Producing Antiretroviral Drugs
99(1)
Two Most Sobering Reports on AIDS-Related Deaths
99(4)
Point of Information 4.3 Current Problems Using Combination Therapy
100(3)
A New Class of Antiretroviral Drugs in Progress: Cell Entry HIV Inhibitors
103(1)
Fusion Inhibitors
103(4)
Box 4.2 Can Combination Therapy Using Nucleoside Analogs with Protease Inhibitors Cure HIV Disease?
105(2)
Pediatric Anti-HIV Therapy
107(1)
Box 4.3 Testing of Anti-HIV Drugs for Post Exposure Prevention
106(1)
Protease Inhibitors and Pregnancy
107(1)
Disclaimer
107(1)
Summary
107(1)
Some AIDS Therapy Information Hotlines
108(1)
Other Organizations and Websites
108(2)
Review Questions
110(1)
References
110(3)
The Immunology of HIV Disease/AIDS
113(31)
Chapter Concepts
113(1)
The Immune System
113(1)
Development of Human Immune System Cells
113(4)
Point of Information 5.1 Class I and Class II Proteins
115(1)
Box 5.1 How Large Is a Trillion?
116(1)
Human Lymphocytes: T Cells and B Cells
117(1)
Antibodies and Viruses
118(7)
Box 5.2 To Understand the Difference Between Health and Disease, People Need To Understand the Immune System!
119(6)
Sidebar 5.1 Measures and Countermeasures: The Human Immune System vs. Viruses
125(1)
Antibodies and HIV Disease
125(2)
Point of Information 5.2 The Big Questions
126(1)
Point of Information 5.3 What Are Cell Receptors?
127(1)
Immune System Dysfunction
127(3)
Point of Information 5.4 The First Look at How HIV's gp
120(8)
Envelope Glycoprotein Changes Shape to Attach to CD4 and Chemokine Receptors
128(2)
FUSIN or CXCKER-4 (R4)
130(1)
CC-CKR-5 (R-5) Receptor
130(1)
Sidebar 4.2 Rantes: A Double-Edged Molecule
131(1)
CCKR-2 (R-2) and CCKR-3 (R-3) Receptors
131(1)
Genetic Resistance to HIV Infection
131(3)
T4 Cell Depletion and Immune Suppression
134(2)
Box 5.3 Cofactors Expedite HIV Infection
134(2)
Impact of T4 Cell Depletion
136(1)
Role of Monocytes and Macrophages in HIV Infection
137(3)
Summary
140(1)
Review Questions
141(1)
References
141(3)
Opportunistic Infections and Cancers Associated with HIV Disease/AIDS
144(26)
Chapter Concepts
144(1)
What is an Opportunistic Disease?
144(1)
The Prevalence of Opportunistic Diseases
145(1)
Prophylaxis Against Opportunistic Infections
145(1)
Opportunistic Infections in HIV-Infected People
145(17)
Point of Information 6.1 The Changing Spectrum of Opportunistic Infections
147(8)
Box 6.1 A Physician's Agonizing Dilemma
155(4)
Point of Information 6.2 Viruses Associated With Cancer
159(1)
Box 6.2 Life Goes On!
160(2)
Cancer in AIDS Patients
162(4)
Point of Information 6.3 Classification of Lymphomas
165(1)
Neuropathies in HIV Disease/AIDS Patients
166(1)
Disclaimer
166(1)
Summary
166(1)
Review Questions
167(1)
References
167(2)
HIV/AIDS Self-Education Quiz
169(1)
A Profile of Biological Indicators for HIV Disease and Progression to AIDS
170(25)
Chapter Concepts
170(1)
HIV Disease Defined
170(1)
Case in Point 7.1 Variation of Initial Symptoms After HIV Infection
171(1)
Stages of HIV Disease
171(7)
Point of Information 7.1 One Mistake Cost Him His Life
175(3)
HIV Disease Without Symptoms, With Symptoms, and AIDS
178(1)
Sidebar 7.1 Primary Case Presentations
178(1)
Aspects of HIV Infection
179(1)
Production of HIV-Specific Antibodies
179(7)
Box 7.1 Evolution of HIV During HIV Disease Progression
180(2)
Box 7.2 Development of AIDS Over Time
182(2)
Box 7.3 Are There Long-Term Adult Nonprogressors of HIV Disease---Yes!---Why?
184(2)
Prognostic Biological Markers Related to AIDS Progression
186(4)
Point of Information 7.2 Viral Load and T4 Cell Counts: Their Use in Clinical Practice
189(1)
HIV Infection of the Central Nervous System
190(1)
Pediatric Clinical Signs and Symptoms
191(1)
Summary
192(1)
Review Questions
192(1)
References
193(2)
Epidemiology and Transmission of the Human Immunodeficiency Virus
195(55)
Chapter Concepts
195(1)
HIV as a Communicable Disease
196(1)
Looking Back 8.1 Public Opinion on How the New Disease---AIDS---Was Transmitted June 1983
196(1)
We Must Stop HIV Transmission Now!
197(1)
Epidemiology of HIV Infection
197(1)
Transmission of Two Strains of HIV (HIV-1/HIV-2)
197(1)
Is HIV Transmitted by Insects?
198(1)
Point of Information 8.1 Consequences of Ignoring HIV
199(1)
HIV Transmission
199(1)
HIV Transmission in Family/Household Settings
199(2)
Box 8.1 A Neighbor's Story: Public Image, Public Fear
200(1)
Noncasual Transmission
201(25)
Looking Back 8.2 Federal Study Committee Advises the Food and Drug Administration on the Acceptance of Blood Donations in the Time of AIDS, July 1983
205(1)
Point of Information 8.2 Danger of HIV Infection via Artificial Insemination
206(4)
Box 8.2 HIV/AIDS Roulette
210(7)
Box 8.3 Gay Men Putting Themselves at High Risk for HIV Infection
217(4)
Point of Information 8.3 Distribution of HIV-Contaminated Blood: France, Germany, the United States, and Other Countries
221(1)
Box 8.4 Sports and HIV/AIDS: Earvin ``Magic'' Johnson and Other Athletes
221(5)
United States: Heterosexual IDU
226(16)
Box 8.5 HIV Transmission: Preparation and Use of Injection Drugs
231(1)
Box 8.6 Assault with HIV
232(3)
Sidebar 8.1 HIV Terrorism, Johannesburg, South Africa
235(1)
Sidebar 8.2 Mexican Doctors Transplant HIV-Infected Kidneys
236(2)
Point of View 8.1 Probably the Number One Risk Cofactor for HIV Is a Sexually Transmitted Disease (STD)
238(3)
Case in Point 8.1 When the Wonderful News ``You're Pregnant'' Becomes a Tragedy
241(1)
Caesarean Section
242(1)
Box 8.7 Is Breast Feeding Policy for Women in Undeveloped Nations Changing?
242(1)
Public Confidence: Acceptance of Current Dogma on Routes of HIV Transmission
243(1)
Box 8.8 HIV and Senior Citizens
243(1)
National AIDS Resources
244(1)
Summary
245(1)
Review Questions
245(1)
References
246(4)
Preventing the Transmission of HIV
250(48)
Chapter Concepts
250(1)
Prevention, Not Treatment, Is the Least Expensive and Most Effective Way to Stop the Spread of AIDS
250(1)
Global Prevention
250(1)
Prevention of Infectious Diseases: HIV/AIDS
251(1)
Preventing the Transmission of HIV
252(3)
Box 9.1 HIV Prevention Education---United States
253(1)
Looking Back 9.1 The ``Magic'' Event: A Force for Prevention, November 1991
254(1)
Behavioral Change
255(2)
New Rules to an Old Game: Promoting Safer Sex
257(13)
Box 9.2 HIV/AIDS Prevention Works?
258(2)
Sidebar 9.1 Two Anecdotes on Condom Use in South Africa
260(2)
Point to Ponder 9.1 Education Versus Risk: It's Not What You Know, It's What You Do
262(1)
Point of Information 9.1 Clarifying the Issues over Condom Use
263(6)
Point of Information 9.2 Questions and Answers About the Female Condom
269(1)
Injection Drug Use and HIV Transmission: The Twin Epidemics
270(1)
HIV Prevention for Injection Drug Users
270(6)
Box 9.3 The Controversy: Providing Sterile Syringes and Needles to Injection Drug Users (IDUs)
273(3)
Prevention of Blood and Blood Product HIV Transmission
276(1)
Infection Control Procedures
277(4)
Box 9.4 Americans Support Sex Education and Condoms in Schools and in TV Ads, and Needle Exchange Programs
278(1)
Box 9.5 Blood Transfusions: A Gift of Life or the Carrier of Death?
279(2)
Partner Notification
281(3)
Point of View 9.1 The Goal of Developing an HIV Vaccine
284(1)
Vaccine Development
284(2)
Vaccine Production
286(1)
DNA Vaccine
286(3)
Point of Information 9.3 HIV Vaccine: Prevention and Therapy
287(2)
Problems in the Search for HIV Vaccine
289(1)
Human HIV Vaccine Trials
290(2)
Update 2001/2002 Vaccinology Break through
292(1)
Summary
293(1)
Review Questions
294(1)
References
294(4)
Prevalence of HIV Infections, AIDS Cases, and Deaths Among Select Groups in the United States and AIDS in Other Countries
298(40)
Chapter Concepts
298(1)
A Word About Data
298(1)
The Millennium: Year 2002
299(1)
Formula for Estimating HIV Infections
300(2)
Behavioral Risk Groups and Statistical Evaluation
302(14)
Box 10.1 The HIV/AIDS Scenario
303(4)
Point to Ponder 10.1 On the Down Low
307(2)
Sidebar 10.1 The Latino Community
309(6)
Point of Information 10.1 Where Older Patients With HIV Disease Can Get Help
315(1)
Estimates of HIV Infection and Future AIDS Cases
316(2)
Box 10.2 HIV/AIDS Data Collection and Deficiencies
317(1)
Point of View 10.1 Justificationfor HIV Case Reporting in the United States
318(1)
Newly Infected
318(3)
U. S. Estimates Lead to Confusion. Whose Figures Are Correct?: Issues of Credibility
321(1)
Shape of the HIV Pandemic: United States
322(1)
Shape of AIDS Pandemic: United States
323(2)
Estimates of Deaths and Years of Potential Life Lost Due to AIDS in the United States
325(3)
Sidebar 10.2 No AIDS-Related Obituaries: First Time in 17 Years
326(1)
Looking Back 10.1
327(1)
United States---Who Is Dying of AIDS?
328(1)
Life Expectancy
329(1)
Connected But Separate
329(3)
Africa Is Dying Through Darwinian Perversion
332(1)
Other Time Bombs: China, India, and Russia
333(1)
Summary
333(1)
Resources
334(1)
Review Questions
335(1)
References
335(3)
Prevalence of HIV Infection and AIDS Cases Among Women, Children, and Teenagers in the United States
338(33)
Chapter Concepts
338(1)
Women and AIDS Worldwide
339(2)
Point of Information 11.1 Africa: Poverty and Rituals Lead to the Spread of HIV
340(1)
Women: HIV-Positive and AIDS Cases---United States
341(9)
Point of Information 11.2 Profile: Women With HIV/AIDS in the United States
341(3)
Point of Information 11.3 HIV Infection Among Women
344(1)
Box 11.1 Women + Sexual Partners + Deception = AIDS
345(3)
Point of View 11.1 One Woman's Comments on Her HIV Disease Treatments
348(1)
Point of Information 11.4 Pregnant of Women and Knowledge of HIV Transmission
349(1)
Box 11.2 Ruth's Poem
350(1)
Internet
350(2)
Box 11.3 HIV-Infected Women: Difficult Choices During Pregnancy
351(1)
Pediatric HIV-Positive and AIDS Cases---United States
352(2)
Orphaned Children Due to HIV Infection and AIDS
354(6)
Looking Back 11.1 Adoption Advertisements for Parents with AIDS
355(1)
Sidebar 11.1 Central America---Honduras
356(3)
Point to Ponder 11.1 Disturbing Thoughts
359(1)
Box 11.4 Johannesburg, South Africa
360(1)
Global HIV Infections in Young Adults
360(2)
Point of View 11.2 Perils of Unsafe Sex
362(1)
Teenagers: HIV-Positive and AIDS Cases---United States
362(1)
HIV/AIDS Won't Affect Us!
363(5)
Point of Information 11.5 HIV-Infected Children: Living Longer---Paying a Price
363(1)
Point of Information 11.6 Federal Public Health Policy Supports Abstinence-Only Program: Education Sex
364(1)
Box 11.5 HIV Spreading Rapidly Among Teenage Gay Males
365(1)
Box 11.6 Teenagers and HIV/AIDS in Africa
366(1)
Point of View 11.3 Thoughts and Comments from a Generation at Risk
366(1)
Sidebar 11.2 Can Life Get Worse Than Being Young, Homeless, and Dying of AIDS?
367(1)
Summary
368(1)
Internet
368(1)
Other Useful Sources
368(1)
Review Questions
368(1)
References
369(2)
Testing for Human Immunodeficiency Virus
371(43)
Chapter Concepts
371(1)
Determining the Presence of Antibody Produced When HIV Is Present
372(1)
Requests for HIV Testing
372(1)
Sidebar 12.1 Annual National HIV Testing Day
372(1)
Reasons for HIV Testing
372(1)
Avoiding HIV Testing
373(1)
Immunodiagnostic Techniques for Detecting Antibodies to HIV
373(1)
ELISA HIV Antibody Test
373(3)
Box 12.1 An Assumption of AIDS Without the HIV Test: It Shatters Lives
374(1)
Looking Back 12.1 The Miami Herald and Chicago Tribune, 1985
375(1)
Understanding the ELISA Test
376(9)
Point of Information 12.1 HIV Testing of Teenagers
378(2)
Box 12.2 Pretest Patient Information
380(2)
Point of Information 12.2 Improved ELISA Testing, Blood Donor Interviews, Screening for p24 Antigen, and Nucleic Acid Testing Lower HIV in Nation's Blood Supply
382(3)
Western Blot Assay
385(2)
Box 12.3 The Performance Rate for the Combined ELISA and Western Blot HIV Test
386(1)
Other Screening and Confirmatory Tests
387(5)
Point of Information 12.3 New ELISA Testing Procedures Reveal Early vs. Late HIV Infection
388(1)
Point of View 12.1 Some Relative Drawbacks to the Current HIV Screening Test---ELISA/Western Blot
389(3)
Rapid HIV Testing
392(3)
Point of Information 12.4 Caution Regarding Rapid Tests
392(2)
Sidebar 12.2 Blood vs. Urine: Outcome of HIV Test May Differ (Discordant Results)
394(1)
Viral Load: Measuring HIV RNA
395(2)
Sidebar 12.3 Viral Load Detection Problems
397(1)
Detection of HIV Infection in Newborns
397(1)
FDA Approves Two Home HIV Antibody Test Kits
397(2)
Reporting HIV Infections
399(1)
Sidebar 12.5 Federal Trade Commission Warns of Poor HIV Home Test Kits
399(1)
Who Should Be Tested for HIV Infection?
400(1)
Why Is HIV Test Information Necessary?
401(4)
Box 12.4 The Physician's Dilemma
401(1)
Point of Information 12.5 Black Ministers Lead by Example
402(2)
Point of Information 12.6 U.S. Public Health Service (USPHS) Recommendations for HIV Counseling and Voluntary Testing for All Pregnant Women
404(1)
Point of Information 12.7 A Weak Link in HIV Testing
405(1)
Testing Competency, and Informed Consent
405(5)
Box 12.5 Boxer Stripped of Featherweight Title After Positive HIV Test
405(3)
Box 12.6 Florida: Health Care Workers Leaks Confidential HIV Information
408(1)
Point of Information 12.8 Legislature Survey of State Confidentiality Laws
409(1)
Person-to-Person: Disclosure of HIV Infection
410(1)
Box 12.7 Confidentiality and Sexual Partner Betrayal
410(1)
Summary
411(1)
Review Questions
411(1)
References
412(2)
AIDS and Society: Knowledge, Attitudes, and Behavior
414(42)
Chapter Concepts
414(1)
The New Millennium and HIV/AIDS
414(1)
HIV/AIDS Is an Unusual Disease
415(1)
AIDS Is Here to Stay
415(1)
AIDS
415(1)
Sidebar 13.1 A Mother's Nightmare
416(1)
Blame Someone, Deja Vu
416(1)
Fear: Panic and Hysteria Over the Spread of HIV/AIDS in the United States
417(1)
Actions of Courage
418(1)
Whom Is the General Public to Believe?
418(7)
Box 13.1 Examples of Uncontrolled Fear and Hostility
419(2)
Point of View 13.1 A Southern University Student's Experience
421(2)
Box 13.1 How Some People Responded After Learning That Someone Had AIDS
423(2)
AIDS Education and Behavior
425(11)
Point of View 13.2 Hatred Expressed
426(1)
Point of View 13.3 Newspaper Headline Shocks Readers
426(1)
Box 13.3 When One With AIDS Comes Forth
427(2)
Point of Information 13.1 After 20 years, Americans Still Say AIDS Is a Top Health Concern for the Nation and the World
429(1)
Box 13.4 The Way We Are
430(1)
Box 13.5 Anecdote: Father and Son Exchange Sex Information
430(1)
Point of View 13.4 The Red Ribbon
431(1)
Sidebar 13.2 Recommended Film: Dawn's Gift
432(1)
Looking Back 13.1
432(1)
Sidebar 13.3 Examples of Adult Reactions to HIV/AIDS vs. the Courts
433(2)
Point of View 13.5 The Right to Privacy
435(1)
The Character of Society
436(10)
Point of Information 13.2 Dealing With Discrimination: The Americans With Disabilities Act
440(2)
Point of Information 13.3 HIV Transmitted by Australian and French Surgeons
442(2)
Box 13.6 My First AIDS Experience
444(1)
Point of Information 13.4 Current View of Health Care Workers Who Are HIV-Infected
445(1)
Federal and Private Sector Financing: Creation of an AIDS Industry
446(2)
U. S. Government Believes HIV/AIDS Is a Threat to National Security
448(1)
Point of Information 13.5 Early Global Response to AIDS and National Security
449(1)
Global HIV/AIDS Funding for Africa
449(4)
Summary
453(1)
Review Questions
454(1)
References
454(2)
Epilogue 456(3)
Answers to Review Questions 459(6)
Glossary 465(8)
Index 473

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program